NCT07471113

Brief Summary

The goal of this study is to learn about the impact of a mobile application-supported education program on women's HPV literacy and their beliefs regarding breast cancer screening. The main questions it aims to answer are:

  • Does a mobile application-supported program increase HPV literacy levels among women?
  • Does this intervention strengthen women's positive beliefs and attitudes toward breast cancer screening? Researchers will examine how this holistic, health-based intervention changes participants' awareness and screening perspectives. Participants will:
  • Use a mobile application designed to provide education on HPV and breast cancer
  • Complete surveys regarding their HPV knowledge and breast cancer screening beliefs before and after the program
  • Engage with health-related content through the mobile platform for the duration of the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 2, 2025

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

November 26, 2025

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2025

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 13, 2026

Completed
Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

2 months

First QC Date

November 26, 2025

Last Update Submit

March 11, 2026

Conditions

Human Papilloma VirusBreast CancerWomen

Keywords

Human Papilloma VirusBreast CancerCervical CancerNursing

Outcome Measures

Primary Outcomes (2)

  • Change in HPV literacy (HPV-LS total score) from baseline (pretest) to post-intervention (posttest) compared between the Mobile Application-Supported Education Group and the Control Group.

    The primary outcome is the change in participants' HPV literacy as measured by the HPV Literacy Scale (HPV; 24 items, 5-point Likert). Total scores range from 24 to 120, with higher scores indicating higher HPV literacy. The outcome will be assessed at baseline (pretest) and post-intervention (posttest) and compared between groups.

    12 MONTH

  • Change in breast cancer screening beliefs (Breast Cancer Screening Beliefs Scale total score and/or subscale scores) from baseline to post-intervention compared between groups.

    Breast Cancer Screening Beliefs: The primary outcome is the change in breast cancer screening beliefs measured by the Breast Cancer Screening Beliefs Scale (13 items, 5-point Likert; transformed scoring 0-100). Higher scores indicate more positive screening beliefs (more favorable attitudes/knowledge and fewer perceived barriers). The outcome will be assessed at baseline (pretest) and post-intervention (posttest) and compared between groups.

    12 MONTH

Study Arms (2)

Mobil-App

EXPERIMENTAL

A mobile application will be implemented as an intervention targeting this group.

Behavioral: mobile application

Control

NO INTERVENTION

No intervention will be made against this group.

Interventions

mobile applicationBEHAVIORAL

A mobile application will be implemented for this group.

Mobil-App

Eligibility Criteria

Age30 Months - 65 Months
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFEMALE
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Women aged 30-65 years
  • Literate (able to read and write)
  • Able to understand and speak Turkish
  • Able to use a smartphone
  • Willing to use the mobile application during the study period and consent to data sharing

You may not qualify if:

  • Having undergone regular breast cancer (mammography) and/or cervical cancer (Pap smear/HPV DNA test) screening within the last 3 years, in accordance with national screening guidelines
  • Previous diagnosis of any cancer
  • Neurological conditions affecting cognitive function (e.g., dementia, Alzheimer's disease) or physical/psychiatric conditions that would seriously limit study participation and mobile app use
  • Pregnancy or breastfeeding
  • Participation in another health-related research study during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atatürk University

Erzurum, 25240, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Breast NeoplasmsUterine Cervical Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesUterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Nihan Türkoğlu

    Ataturk University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

November 26, 2025

First Posted

March 13, 2026

Study Start

November 2, 2025

Primary Completion

December 25, 2025

Study Completion

January 2, 2026

Last Updated

March 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)